ANAPTYSBIO INC. - COMMON STOCK
25.47
16-May-24 14:59:54
15 minutes delayed
Stocks
-0.13
-0.51%
Today's range
25.04 - 25.78
ISIN
N/A
Source
NASDAQ
-
07 Mar 2022 07:50:00 By Nasdaq GlobeNewswire
-
AnaptysBio To Present at the 40th Annual J.P. Morgan Healthcare Conference
05 Jan 2022 15:05:00 By Nasdaq GlobeNewswire
-
AnaptysBio Announces Appointment of Daniel Faga to Board of Directors
29 Nov 2021 15:05:50 By Nasdaq GlobeNewswire
-
AnaptysBio To Present at the 2021 Jefferies London Healthcare Conference
15 Nov 2021 18:24:01 By Nasdaq GlobeNewswire
-
AnaptysBio Announces Positive Rosnilimab Healthy Volunteer Phase 1 Top-Line Data
15 Nov 2021 08:00:01 By Nasdaq GlobeNewswire
-
AnaptysBio Announces Third Quarter 2021 Financial Results and Provides Pipeline Updates
04 Nov 2021 15:05:03 By Nasdaq GlobeNewswire
-
25 Oct 2021 15:37:00 By Nasdaq GlobeNewswire
-
02 Oct 2021 11:00:00 By Nasdaq GlobeNewswire
-
AnaptysBio to Participate in the H.C. Wainwright 23rd Annual Global Investment Conference
09 Sep 2021 15:05:00 By Nasdaq GlobeNewswire
-
17 Aug 2021 15:32:07 By Nasdaq GlobeNewswire
-
AnaptysBio to Present at the 2021 Jefferies Virtual Healthcare Conference
27 May 2021 15:15:00 By Nasdaq GlobeNewswire
-
AnaptysBio Announces First Quarter 2021 Financial Results and Provides Pipeline Updates
04 May 2021 15:05:01 By Nasdaq GlobeNewswire
-
23 Apr 2021 09:31:07 By Nasdaq GlobeNewswire
-
FDA Approves JEMPERLI (dostarlimab-gxly) for dMMR Endometrial Cancer
22 Apr 2021 15:12:22 By Nasdaq GlobeNewswire
-
AnaptysBio Announces Appointment of Oleg Nodelman to Board of Directors
12 Apr 2021 15:00:00 By Nasdaq GlobeNewswire
-
25 Feb 2021 15:05:01 By Nasdaq GlobeNewswire
-
AnaptysBio to Present at the 39th Annual J.P. Morgan Healthcare Conference
07 Jan 2021 15:15:00 By Nasdaq GlobeNewswire